AKT1 and cancer: Increasing evidence has reported that phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) pathway contributes to cancer initiation and development, such as tumorigenesis, inhibition of apoptosis, proliferation, and chemoresistance6.